Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin

Hana Totary-Jain, Despina Sanoudou, Iddo Z. Ben-Dov, Cula N. Dautriche, Paolo Guarnieri, Steven O. Marx, Thomas Tuschl, Andrew R. Marks

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The mammalian target of rapamycin (mTOR) is a central regulator of cell proliferation that is often deregulated in cancer. Inhibitors of mTOR, including rapamycin and its analogues, are being evaluated as antitumor agents. For their promise to be fulfilled, it is of paramount importance to identify the mechanisms of resistance and develop novel therapies to overcome it. Given the emerging role of microRNAs (miRNAs) in tumorigenesis, we hypothesized thatmiRNAscould play important roles in the response of tumors tomTORinhibitors. Long-term rapamycin treatment showed extensive reprogramming of miRNA expression, characterized by up-regulation of miR-17-92 and related clusters and down-regulation of tumor suppressor miRNAs. Inhibition of members of the miR-17-92 clusters or delivery of tumor suppressor miRNAs restored sensitivity to rapamycin. This study identifies miRNAs as new downstream components of the mTOR-signaling pathway, which may determine the response of tumors to mTOR inhibitors. It also identifies potential markers to assess the efficacy of treatment and provides novel therapeutic targets to treat rapamycin-resistant tumors.

Original languageEnglish
Pages (from-to)6034-6044
Number of pages11
JournalJournal of Biological Chemistry
Volume288
Issue number9
DOIs
Publication statusPublished - 1 Mar 2013
Externally publishedYes

Fingerprint

Sirolimus
MicroRNAs
Transcriptome
Tumors
Neoplasms
Cell proliferation
Antineoplastic Agents
Carcinogenesis
Up-Regulation
Down-Regulation
Cell Proliferation
Therapeutics

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Totary-Jain, H., Sanoudou, D., Ben-Dov, I. Z., Dautriche, C. N., Guarnieri, P., Marx, S. O., ... Marks, A. R. (2013). Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin. Journal of Biological Chemistry, 288(9), 6034-6044. https://doi.org/10.1074/jbc.M112.416446

Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin. / Totary-Jain, Hana; Sanoudou, Despina; Ben-Dov, Iddo Z.; Dautriche, Cula N.; Guarnieri, Paolo; Marx, Steven O.; Tuschl, Thomas; Marks, Andrew R.

In: Journal of Biological Chemistry, Vol. 288, No. 9, 01.03.2013, p. 6034-6044.

Research output: Contribution to journalArticle

Totary-Jain, H, Sanoudou, D, Ben-Dov, IZ, Dautriche, CN, Guarnieri, P, Marx, SO, Tuschl, T & Marks, AR 2013, 'Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin', Journal of Biological Chemistry, vol. 288, no. 9, pp. 6034-6044. https://doi.org/10.1074/jbc.M112.416446
Totary-Jain H, Sanoudou D, Ben-Dov IZ, Dautriche CN, Guarnieri P, Marx SO et al. Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin. Journal of Biological Chemistry. 2013 Mar 1;288(9):6034-6044. https://doi.org/10.1074/jbc.M112.416446
Totary-Jain, Hana ; Sanoudou, Despina ; Ben-Dov, Iddo Z. ; Dautriche, Cula N. ; Guarnieri, Paolo ; Marx, Steven O. ; Tuschl, Thomas ; Marks, Andrew R. / Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin. In: Journal of Biological Chemistry. 2013 ; Vol. 288, No. 9. pp. 6034-6044.
@article{66a8c8c7901c452aae5ca06f888744b7,
title = "Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin",
abstract = "The mammalian target of rapamycin (mTOR) is a central regulator of cell proliferation that is often deregulated in cancer. Inhibitors of mTOR, including rapamycin and its analogues, are being evaluated as antitumor agents. For their promise to be fulfilled, it is of paramount importance to identify the mechanisms of resistance and develop novel therapies to overcome it. Given the emerging role of microRNAs (miRNAs) in tumorigenesis, we hypothesized thatmiRNAscould play important roles in the response of tumors tomTORinhibitors. Long-term rapamycin treatment showed extensive reprogramming of miRNA expression, characterized by up-regulation of miR-17-92 and related clusters and down-regulation of tumor suppressor miRNAs. Inhibition of members of the miR-17-92 clusters or delivery of tumor suppressor miRNAs restored sensitivity to rapamycin. This study identifies miRNAs as new downstream components of the mTOR-signaling pathway, which may determine the response of tumors to mTOR inhibitors. It also identifies potential markers to assess the efficacy of treatment and provides novel therapeutic targets to treat rapamycin-resistant tumors.",
author = "Hana Totary-Jain and Despina Sanoudou and Ben-Dov, {Iddo Z.} and Dautriche, {Cula N.} and Paolo Guarnieri and Marx, {Steven O.} and Thomas Tuschl and Marks, {Andrew R.}",
year = "2013",
month = "3",
day = "1",
doi = "10.1074/jbc.M112.416446",
language = "English",
volume = "288",
pages = "6034--6044",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "9",

}

TY - JOUR

T1 - Reprogramming of the MicroRNA transcriptome mediates resistance to rapamycin

AU - Totary-Jain, Hana

AU - Sanoudou, Despina

AU - Ben-Dov, Iddo Z.

AU - Dautriche, Cula N.

AU - Guarnieri, Paolo

AU - Marx, Steven O.

AU - Tuschl, Thomas

AU - Marks, Andrew R.

PY - 2013/3/1

Y1 - 2013/3/1

N2 - The mammalian target of rapamycin (mTOR) is a central regulator of cell proliferation that is often deregulated in cancer. Inhibitors of mTOR, including rapamycin and its analogues, are being evaluated as antitumor agents. For their promise to be fulfilled, it is of paramount importance to identify the mechanisms of resistance and develop novel therapies to overcome it. Given the emerging role of microRNAs (miRNAs) in tumorigenesis, we hypothesized thatmiRNAscould play important roles in the response of tumors tomTORinhibitors. Long-term rapamycin treatment showed extensive reprogramming of miRNA expression, characterized by up-regulation of miR-17-92 and related clusters and down-regulation of tumor suppressor miRNAs. Inhibition of members of the miR-17-92 clusters or delivery of tumor suppressor miRNAs restored sensitivity to rapamycin. This study identifies miRNAs as new downstream components of the mTOR-signaling pathway, which may determine the response of tumors to mTOR inhibitors. It also identifies potential markers to assess the efficacy of treatment and provides novel therapeutic targets to treat rapamycin-resistant tumors.

AB - The mammalian target of rapamycin (mTOR) is a central regulator of cell proliferation that is often deregulated in cancer. Inhibitors of mTOR, including rapamycin and its analogues, are being evaluated as antitumor agents. For their promise to be fulfilled, it is of paramount importance to identify the mechanisms of resistance and develop novel therapies to overcome it. Given the emerging role of microRNAs (miRNAs) in tumorigenesis, we hypothesized thatmiRNAscould play important roles in the response of tumors tomTORinhibitors. Long-term rapamycin treatment showed extensive reprogramming of miRNA expression, characterized by up-regulation of miR-17-92 and related clusters and down-regulation of tumor suppressor miRNAs. Inhibition of members of the miR-17-92 clusters or delivery of tumor suppressor miRNAs restored sensitivity to rapamycin. This study identifies miRNAs as new downstream components of the mTOR-signaling pathway, which may determine the response of tumors to mTOR inhibitors. It also identifies potential markers to assess the efficacy of treatment and provides novel therapeutic targets to treat rapamycin-resistant tumors.

UR - http://www.scopus.com/inward/record.url?scp=84874774756&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874774756&partnerID=8YFLogxK

U2 - 10.1074/jbc.M112.416446

DO - 10.1074/jbc.M112.416446

M3 - Article

VL - 288

SP - 6034

EP - 6044

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 9

ER -